Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S
Second Department of Internal Medicine, Mie University School of Medicine, Mie Ken, Japan.
Am J Hematol. 1992 Jul;40(3):167-70. doi: 10.1002/ajh.2830400303.
Plasma cytokine levels were examined in 13 patients with thrombotic thrombocytopenic purpura (TTP). Auto-antibodies, platelet-associated immunoglobulin G, and platelet aggregating factor were detected in many of these patients and high-molecular-weight bands of von Willebrand factor multimers were reduced in 9 of 10 patients examined. Complete remission (CR) was attained in 7 of the 13 patients, but 6 died. Tumor necrosis factor (TNF), Interleukin (IL)-1 beta, IL-6, and soluble IL-2 receptor showed marked increases at onset and decreased at CR. The prognosis tended to be poor in patients with increased IL-6 and soluble IL-2 receptor levels. These findings suggest that immunological mechanisms, such as the activation of macrophage, are involved in the pathogenesis of TTP and are reflected in the plasma cytokine levels.
对13例血栓性血小板减少性紫癜(TTP)患者的血浆细胞因子水平进行了检测。在许多这类患者中检测到自身抗体、血小板相关免疫球蛋白G和血小板聚集因子,并且在10例接受检测的患者中,有9例的血管性血友病因子多聚体高分子量条带减少。13例患者中有7例实现完全缓解(CR),但有6例死亡。肿瘤坏死因子(TNF)、白细胞介素(IL)-1β、IL-6和可溶性IL-2受体在发病时显著升高,在CR时下降。IL-6和可溶性IL-2受体水平升高的患者预后往往较差。这些发现表明,诸如巨噬细胞激活等免疫机制参与了TTP的发病机制,并反映在血浆细胞因子水平上。